08 Feb 2024 The Therapeutics Initiative welcomes Dr. Siyana Kurteva
The Therapeutics Initiative is pleased to extend a warm welcome to the newest member of our team, Dr. Siyana Kurteva.
Dr. Kurteva is an epidemiologist focused on generating observational research that uses best scientific practices to improve prescribing and medication-related safety issues. She received her Ph.D. in Epidemiology, specializing in applied pharmacoepidemiology and epidemiologic methods, from the Department of Epidemiology, Biostatistics and Public Health at the School of Population and Global Health at McGill University. Previously, she completed her undergraduate training in Pharmacology in the Department of Pharmacology and Therapeutics at McGill University.
Her research portfolio consists of observational studies focused on preventive strategies examining the causal effects of high-risk medication use on the risk of adverse events, evaluating postoperative outcomes and healthcare services utilization in a high prevalence and high social impact settings. She developed expertise in observational studies using comprehensive linked data from multiple data sources such as health care administrative databases, electronic health records, and patient-reported post-discharge health outcomes.
Some of the methods that she has used in her research include the application of marginal structural models, survival and regression models, competing risk analyses, inverse-probability treatment weights, informative censoring, propensity-score matched analyses and cumulative effect of exposures via novel weighted approaches. Her research interests are in developing policies and prevention strategies targeted at minimizing the harm linked to high-risk psychoactive medication use and its related morbidity and mortality. Siyana will contribute to the TI’s PharmacoEpidemiology Working Group and Scientific Information and Education Committee.
You can read more about her bio on our Members Page.
Welcome Siyana!
No Comments